More than 30 mutations of BRAF gene associated with human cancers have been identified. Presence of these mutations increases tumor growth and metastasis. BRAF V600E mutation has been detected in melanomas, thyroid tumors & hairy cell leukemia. Patients exhibiting these mutations benefit from BRAF inhibitors which are extremely effective against Malignant Melanomas & thyroid cancer.